BioCryst’s Oral Option To Take On Injectables In HAE Prophylaxis Market

 
• By Joseph Haas
FDA Approved typed words on a vintage typewriter
BioCryst gets FDA approval of first oral prophylaxis for HAE

More from New Products

More from Scrip